Oxford Asset Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Oxford Asset Management’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-446,618	Closed	-$9.34M	–	961
2016 Q3	$9.34M	Buy	446,618 +132,292	+42%	+$1.52M	0.29%	78
2016 Q2	$3.39M	Buy	314,326 +216,544	+221%	+$1.85M	0.11%	246
2016 Q1	$648K	Buy	+97,782	New	+$889K	0.02%	569

Oxford Asset Management's VTAE Position: Q4 2016 in Review

Oxford Asset Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 446,618 shares — an estimated $9.34M sold.

Oxford Asset Management first reported a position in VTAE in Q1 2016 and held it in 3 quarters. The position peaked at $9.34M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Oxford Asset Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Oxford Asset Management sold 446,618 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $9.34M.
Oxford Asset Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2016 and held it in 3 quarters.
Oxford Asset Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $9.34M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Oxford Asset Management's 13F filing for Q4 2016, filed 9 Feb 2017.